The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

The market is driven by rising diabetes, GLP-1 growth, insulin innovations, and demand for oral therapies. HYDERABAD, TELANGANA, INDIA, June 3, 2025 /EINPresswire.com/ -- The diabetes drugs market, ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic ...

People with type 1 diabetes require insulin to live, while those with type 2 diabetes use insulin and other medications to ...

At the recent American Association of Clinical Endocrinology (AACE) annual meeting, experts highlighted new approaches to identifying and managing hypercortisolism in patients with type 2 diabetes, ...

Diabetes Canada says it's received a surge in reports from people who've seen ads for or bought products that use the charity ...

For many of us, the day doesn't start until we've had our first cup of coffee. It's comforting, energizing, and one of the ...

A recent study reveals that weight-loss medications such as Ozempic may reduce the risk of obesity-related cancers, including ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.

Concurrent hypertension and type 2 diabetes significantly increase mortality risk, emphasizing the need for targeted health ...